Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Salbutamol is marketed in Australia as Asmol CFC-Free, Butamol and Ventolin CFC-Free, among others.
Asthma Clinical criteria: Patient must be unable to use this drug delivered from an oral pressurised inhalation device via a spacer.
Chronic obstructive pulmonary disease (COPD) Clinical criteria: Patient must be unable to use this drug delivered from an oral pressurised inhalation device via a spacer.
Bronchospasm Clinical criteria: Patient must be unable to achieve co-ordinated use of other metered dose inhalers containing this drug.
“Salbutamol is a relatively selective beta-2-adrenoreceptor stimulant.”
“The elimination half-life of inhaled or oral salbutamol is between 2.7 and 5 hours.”
Salbutamol is marketed in Australia as Asmol CFC-Free, Butamol and Ventolin CFC-Free, among others.
9 brand names are recorded against this substance from the TGA eBS Product Information repository. The full list is in the Also known as card.
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.